Evan Levine's Net Worth
$37.8 Million
Who is Evan Levine?
Evan Levine has an estimated net worth of $37.8 Million. This is based on reported shares across multiple companies, which include QUANTRX BIOMEDICAL CORP, NURX PHARMACEUTICALS, INC., Probility Media Corp, SILVERGRAPH INTERNATIONAL INC, and ADVENTRX PHARMACEUTICALS INC.
SEC CIK
Evan Levine's CIK is 0001199838
Past Insider Trading and Trends
2006 was Evan Levine's most active year for acquiring shares with 13 total transactions. Evan Levine's most active month to acquire stocks was the month of September. 2007 was Evan Levine's most active year for disposing of shares, totalling 13 transactions. Evan Levine's most active month to dispose stocks was the month of January. 2016 saw Evan Levine paying a total of $3,942,436.80 for 4,928,046 shares, this is the most they've acquired in one year. In 2007 Evan Levine cashed out on 997,009 shares for a total of $697,477.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUANTRX BIOMEDICAL CORP (QTXB) Snapshot price: $0.0049
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.76% | -993.01K |
$0.70 | -$695,106.30 | 3.79M |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NURX PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.01% | -11.50K |
—
|
—
| 1.13M |
Jun 8 - Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Probility Media Corp No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,119.75% | 77.78M |
—
| $70,000.00 | 84.72M |
Nov 30
| |||
Form 4
| +294.75% | 4.93M |
$0.80 | $3,942,436.80 | 6.6M |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SILVERGRAPH INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADVENTRX PHARMACEUTICALS INC (SVRA) Snapshot price: $4.705
CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.11% | 5K |
$0.51 | $2,530.00 | 4.39M |
Feb 8
| |||
Form 4
| +0.23% | 10K |
$1.94 | $5,670.82 | 4.39M |
Oct 4 - Feb 5
| |||
Form 4
|
∞
| 60K |
$0.45 | $26,800.00 | 60K |
Dec 14
| |||
Form 4
| +0.58% | 25K |
$0.50 | $12,500.00 | 4.32M |
Jun 28
| |||
Form 4
| +0.59% | 25K |
$0.50 | $12,500.00 | 4.29M |
Jun 26
| |||
Form 4
| +0.59% | 25K |
$0.50 | $12,500.00 | 4.27M |
Jun 23
| |||
Form 4
| +0.59% | 25K |
$0.50 | $12,500.00 | 4.25M |
Jun 21
| |||
Form 4
| +0.61% | 25.6K |
$0.50 | $12,800.50 | 4.22M |
Apr 24
| |||
Form 4
|
—
|
0
|
$2.03 | -$165,969.90 | 4.19M |
Scheduled
|
Sep 12 - Sep 14
| ||
| No matching records found | |||||||||